This purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of a bacteriophage therapy in a patient with a methicillin-susceptible Enterococcus faecium (E. faecium) prosthetic joint infection (PJI) of the hip. We have exhausted all surgical and medical management of PJI for our patient.
The phage will be administered to the study patient during a 14 days period via intravenous and intra-articular. The patient will be monitored in clinic for up to 1 year.
Willingness to provide signed and dated informed consent form to participate in the clinical study
Chronic prosthetic joint infection
History of multiple surgical and medication managements with no success
below 18 years of age
Orthopaedic Innovation Centre
Lead sponsor
Cytophage Technologies Inc.
Collaborator
Ottawa Hospital Research Institute
Collaborator